계명대학교 의학도서관 Repository

Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)

Metadata Downloads
Author(s)
Jae Seung KangLydia MokJin Seok HeoIn Woong HanSang Hyun ShinYoo-Seok YoonHo-Seong HanDae Wook HwangJae Hoon LeeWoo Jung LeeSang Jae ParkJoon Seong ParkYonghoon KimHuisong LeeYoung-Dong YuJae Do YangSeung Eun LeeIl Young ParkChi-Young JeongYounghoon RohSeong-Ryong KimJu Ik MoonSang Kuon LeeHee Joon KimSeungyeoun LeeHongbeom KimWooil KwonChang-Sup LimJin-Young JangTaesung Park
Keimyung Author(s)
Kim, Yong Hoon
Department
Dept. of Surgery (외과학)
Journal Title
Gut and Liver
Issued Date
2021
Volume
15
Issue
6
Keyword
Pancreatic neoplasmsSurvivalPrognosis
Abstract
Background/Aims:
Several prediction models for evaluating the prognosis of nonmetastatic resected pancreatic ductal adenocarcinoma (PDAC) have been developed, and their performances were reported to be superior to that of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system. We developed a prediction model to evaluate the prognosis of resected PDAC and externally validated it with data from a nationwide Korean database.

Methods:
Data from the Surveillance, Epidemiology and End Results (SEER) database were utilized for model development, and data from the Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP) database were used for external validation. Potential candidate variables for model development were age, sex, histologic differentiation, tumor location, adjuvant chemotherapy, and the AJCC 8th staging system T and N stages. For external validation, the concordance index (C-index) and time-dependent area under the receiver operating characteristic curve (AUC) were evaluated.

Results:
Between 2004 and 2016, data from 9,624 patients were utilized for model development, and data from 3,282 patients were used for external validation. In the multivariate Cox proportional hazard model, age, sex, tumor location, T and N stages, histologic differentiation, and adjuvant chemotherapy were independent prognostic factors for resected PDAC. After an exhaustive search and 10-fold cross validation, the best model was finally developed, which included all prognostic variables. The C-index, 1-year, 2-year, 3-year, and 5-year time-dependent AUCs were 0.628, 0.650, 0.665, 0.675, and 0.686, respectively.

Conclusions:
The survival prediction model for resected PDAC could provide quantitative survival probabilities with reliable performance. External validation studies with other nationwide databases are needed to evaluate the performance of this model.
Keimyung Author(s)(Kor)
김용훈
Publisher
School of Medicine (의과대학)
Citation
Jae Seung Kang et al. (2021). Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP). Gut and Liver, 15(6), 912–921. doi: 10.5009/gnl20306
Type
Article
ISSN
2005-1212
Source
https://www.gutnliver.org/journal/view.html?uid=1838
DOI
10.5009/gnl20306
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/43853
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Surgery (외과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.